RIVANNA launches a Global FIH Trial for its Accuro XV Musculoskeletal Imaging System
Shots:
- RIVANNA has initiated the global FIH research project utilizing the Accuro XV musculoskeletal imaging system, following its $30.5M funding agreement with BARDA, carried out in 2023
- This study (n=200) aims to assess safety, compatibility with ED workflows, and capability to produce automated diagnostic ultrasound images using Accuro XV. Also, aims to enhance emergency departments by quickly detecting soft tissue injuries and enabling accurate treatment and timely patient discharge
- This project has received full or partial federal funds from the Department of Health and Human Services, ASPR & the BARDA, under contract number 75A50121C00035
Ref: RIVANNA | Image: RIVANNA
Related News:- Roche’s Ventana CLDN18 (43-14A) RxDx Assay Receives CE Mark Approval to Diagnose G/GEJ Cancer Patients with CLDN18 Protein Expression
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
A passionate content writer with expertise in delivering high-quality and engaging content, Dipanshu is a keen reader and a versatile writer. Dipanshu dedicatedly covers news ranging from biopharma, life sciences, biotech, and MedTech to diagnostics and animal health companies. He can be contacted at connect@pharmashots.com
